留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

人羊膜上皮细胞外泌体对高糖环境下HaCaT增殖和迁移的影响及其机制

卫裴 许钊荣 陈艺敏 陈晓东 陈昭宏

卫裴, 许钊荣, 陈艺敏, 等. 人羊膜上皮细胞外泌体对高糖环境下HaCaT增殖和迁移的影响及其机制[J]. 中华烧伤杂志, 2021, 37(12): 1175-1184. DOI: 10.3760/cma.j.cn501120-20210424-00154.
引用本文: 卫裴, 许钊荣, 陈艺敏, 等. 人羊膜上皮细胞外泌体对高糖环境下HaCaT增殖和迁移的影响及其机制[J]. 中华烧伤杂志, 2021, 37(12): 1175-1184. DOI: 10.3760/cma.j.cn501120-20210424-00154.
Wei P,Xu ZR,Chen YM,et al.The effect and mechanism of exosomes derived from human amniotic epithelial cells on the proliferation and migration of HaCaT in high glucose environment[J].Chin J Burns,2021,37(12):1175-1184.DOI: 10.3760/cma.j.cn501120-20210424-00154.
Citation: Wei P,Xu ZR,Chen YM,et al.The effect and mechanism of exosomes derived from human amniotic epithelial cells on the proliferation and migration of HaCaT in high glucose environment[J].Chin J Burns,2021,37(12):1175-1184.DOI: 10.3760/cma.j.cn501120-20210424-00154.

人羊膜上皮细胞外泌体对高糖环境下HaCaT增殖和迁移的影响及其机制

doi: 10.3760/cma.j.cn501120-20210424-00154
基金项目: 

福建省医疗“创双高”建设项目 202176

详细信息
    通讯作者:

    陈昭宏,Email:doctorczh@163.com

The effect and mechanism of exosomes derived from human amniotic epithelial cells on the proliferation and migration of HaCaT in high glucose environment

Funds: 

The Construction Program of Medical "Double High" in Fujian Province of China 202176

More Information
    Corresponding author: Chen Zhaohong, Email: doctorczh@163.com
  • 摘要:   目的  探讨人羊膜上皮细胞外泌体(hAEC-Exo)对高糖环境下HaCaT增殖和迁移的作用及其相关机制。  方法  采用实验研究方法。取2019年1—6月于福建医科大学附属协和医院妇产科10名足月分娩健康孕妇羊膜组织,分离原代人羊膜上皮细胞(hAEC)。观察培养第2、4、7天原代hAEC生长状态和形态改变,采用流式细胞术检测细胞表面标志物CD73、CD90、CD29、CD34及人白细胞抗原DR(HLA-DR)的表达,取第2~4代细胞用于后续实验。超速离心法分离hAEC-Exo。将HaCaT与hAEC-Exo共培养3 h,采用倒置荧光显微镜观察HaCaT对hAEC-Exo的摄取情况。取HaCaT,分为磷酸盐缓冲液(PBS)组、hAEC-Exo组和二甲基亚砜(DMSO)+PBS组、DMSO+hAEC-Exo组、LY294002+hAEC-Exo组,每组3孔,并进行相应处理,采用细胞计数试剂盒8(CCK-8)法检测培养0(即刻)、12、24、36、48、60 h细胞增殖活力;划痕试验检测划痕后0、24、48、72 h划痕愈合情况,并计算划痕愈合率;Transwell实验检测培养48 h穿膜细胞数;蛋白质印迹法检测培养24 h后磷脂酰肌醇3-激酶-蛋白激酶B-哺乳动物雷帕霉素靶蛋白(PI3K-Akt-mTOR)通路相关的哺乳动物雷帕霉素靶蛋白(mTOR)、磷酸化mTOR(p-mTOR)、蛋白激酶B(Akt)、磷酸化Akt(p-Akt)的蛋白表达。对数据行重复测量方差分析、单因素方差分析及独立样本t检验。  结果  原代hAEC培养第2天多数呈卵圆形,大小均一;培养第4、7天,细胞形态呈典型的鹅卵石样单层排列。原代hAEC高表达间充质干细胞表面标志物CD73、CD90及CD29,不表达或低表达造血干细胞相关表面标志物CD34及HLA-DR。培养3 h,hAEC-Exo成功被HaCaT内吞入细胞质,并聚集于细胞核周围。培养12、24、36、48、60 h,hAEC-Exo组HaCaT增殖活力明显高于PBS组(t=3.691、10.861、12.121、10.531、14.931,P<0.01)。划痕后24、48、72 h,PBS组HaCaT划痕愈合率明显低于hAEC-Exo组(t=3.342、6.427、5.485,P<0.05或P<0.01)。培养48 h,hAEC-Exo组HaCaT穿膜数显著多于PBS组(t=5.385,P<0.01)。培养24 h,hAEC-Exo组HaCaT中p-mTOR和p-Akt蛋白表达量明显高于PBS组(t=4.240、5.586,P<0.01),2组HaCaT中mTOR和Akt蛋白表达量相近(P>0.05)。培养24 h,DMSO+hAEC-Exo组HaCaT中p-mTOR和p-Akt的蛋白表达量明显高于DMSO+PBS组(t=6.155、8.338,P<0.01)和LY294002+hAEC-Exo组(t=5.030、3.960,P<0.01),3组HaCaT中mTOR和Akt蛋白表达量相近(P>0.05)。DMSO+hAEC-Exo组HaCaT培养12、24、36、48、60 h增殖活力为0.78±0.05、1.23±0.07、1.60±0.09、1.86±0.09、2.03±0.08,明显高于DMSO+PBS组的0.46±0.04、0.69±0.07、0.98±0.08、1.16±0.08、1.26±0.11(t=4.376、7.398、8.488、9.766、10.730,P<0.01);DMSO+hAEC-Exo组HaCaT培养24、36、48、60 h增殖活力明显高于LY294002+hAEC-Exo组的0.96±0.09、1.20±0.08、1.39±0.08、1.55±0.10(t=3.639、5.447、6.605、6.693,P<0.05或P<0.01)。DMSO+hAEC-Exo组HaCaT划痕后24、48、72 h划痕愈合率明显高于DMSO+PBS组(t=4.003、6.349、7.714,P<0.01)和LY294002+hAEC-Exo组(t=3.805、4.676、4.067,P<0.05或P<0.01)。培养48 h,DMSO+hAEC-Exo组HaCaT穿膜数明显多于DMSO+PBS组和LY294002+hAEC-Exo组(t=7.464、1.232,P<0.01)。  结论  PI3K-Akt-mTOR通路介导hAEC-Exo促进高糖环境下HaCaT增殖和迁移。

     

  • 参考文献(27)

    [1] BurgessJL,WyantWA,Abdo AbujamraB,et al.Diabetic wound-healing science[J].Medicina (Kaunas),2021,57(10):1072. DOI: 10.3390/medicina57101072.
    [2] RatajczakJ,WysoczynskiM,HayekF,et al.Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication[J].Leukemia,2006,20(9):1487-1495.DOI: 10.1038/sj.leu.2404296.
    [3] FerreiraADF, GomesDA. Stem cell extracellular vesicles in skin repair[J].Bioengineering (Basel),2018,6(1):4. DOI: 10.3390/bioengineering6010004.
    [4] van NielG, D'AngeloG, RaposoG.Shedding light on the cell biology of extracellular vesicles[J].Nat Rev Mol Cell Biol,2018,19(4):213-228. DOI: 10.1038/nrm.2017.125.
    [5] ZhangW,BaiX,ZhaoB,et al.Cell-free therapy based on adipose tissue stem cell-derived exosomes promotes wound healing via the PI3K/Akt signaling pathway[J].Exp Cell Res,2018,370(2):333-342. DOI: 10.1016/j.yexcr.2018.06.035.
    [6] ZhangJ,ChenC,HuB,et al.Exosomes derived from human endothelial progenitor cells accelerate cutaneous wound healing by promoting angiogenesis through Erk1/2 signaling[J].Int J Biol Sci,2016,12(12):1472-1487.DOI: 10.7150/ijbs.15514.
    [7] LiX, LiuL, YangJ, et al. Exosome derived from human umbilical cord mesenchymal stem cell mediates miR-181c attenuating burn-induced excessive inflammation[J]. EBioMedicine, 2016,8:72-82. DOI: 10.1016/j.ebiom.2016.04.030.
    [8] ZhaoB,LiX,ShiX,et al.Exosomal microRNAs derived from human amniotic epithelial cells accelerate wound healing by promoting the proliferation and migration of fibroblasts[J].Stem Cells Int,2018,2018:5420463.DOI: 10.1155/2018/5420463.
    [9] ZhengY,ZhengS,FanX,et al.Amniotic epithelial cells accelerate diabetic wound healing by modulating inflammation and promoting neovascularization[J].Stem Cells Int,2018,2018:1082076.DOI: 10.1155/2018/1082076.
    [10] ZhengY,JiS,WuH,et al.Topical administration of cryopreserved living micronized amnion accelerates wound healing in diabetic mice by modulating local microenvironment[J].Biomaterials,2017,113:56-67.DOI: 10.1016/j.biomaterials.2016.10.031.
    [11] WeiP,ZhongC,YangX,et al.Exosomes derived from human amniotic epithelial cells accelerate diabetic wound healing via PI3K-AKT-mTOR-mediated promotion in angiogenesis and fibroblast function[J/OL].Burns Trauma,2020,8:tkaa020[2021-04-24].https://pubmed.ncbi.nlm.nih.gov/32923490/.DOI: 10.1093/burnst/tkaa020.
    [12] XiaoGY,ChengCC,ChiangYS,et al.Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy[J].Sci Rep,2016,6:23120.DOI: 10.1038/srep23120.
    [13] FortunatoO,GaspariniP,BoeriM,et al.Exo-miRNAs as a new tool for liquid biopsy in lung cancer[J].Cancers (Basel),2019,11(6):888. DOI: 10.3390/cancers11060888.
    [14] HuY,RaoSS,WangZX,et al.Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function[J].Theranostics,2018,8(1):169-184.DOI: 10.7150/thno.21234.
    [15] HuangH,CuiW,QiuW,et al.Impaired wound healing results from the dysfunction of the Akt/mTOR pathway in diabetic rats[J].J Dermatol Sci,2015,79(3):241-251.DOI: 10.1016/j.jdermsci.2015.06.002.
    [16] CastilhoRM,SquarizeCH,GutkindJS.Exploiting PI3K/mTOR signaling to accelerate epithelial wound healing[J].Oral Dis,2013,19(6):551-558.DOI: 10.1111/odi.12070.
    [17] ShawTJ,MartinP.Wound repair: a showcase for cell plasticity and migration[J].Curr Opin Cell Biol,2016,42:29-37.DOI: 10.1016/j.ceb.2016.04.001.
    [18] HuSC,LanCE.High-glucose environment disturbs the physiologic functions of keratinocytes: focusing on diabetic wound healing[J].J Dermatol Sci,2016,84(2):121-127.DOI: 10.1016/j.jdermsci.2016.07.008.
    [19] ZhaoB,LiuJQ,YangC,et al.Human amniotic epithelial cells attenuate TGF-β1-induced human dermal fibroblast transformation to myofibroblasts via TGF-β1/Smad3 pathway[J].Cytotherapy,2016,18(8):1012-1024.DOI: 10.1016/j.jcyt.2016.04.009.
    [20] ZhaoB,LiuJQ,ZhengZ,et al.Human amniotic epithelial stem cells promote wound healing by facilitating migration and proliferation of keratinocytes via ERK, JNK and AKT signaling pathways[J].Cell Tissue Res,2016,365(1):85-99.DOI: 10.1007/s00441-016-2366-1.
    [21] CamussiG,DeregibusMC,BrunoS,et al.Exosomes/microvesicles as a mechanism of cell-to-cell communication[J].Kidney Int,2010,78(9):838-848.DOI: 10.1038/ki.2010.278.
    [22] FriedmanRC,FarhKK,BurgeCB,et al.Most mammalian mRNAs are conserved targets of microRNAs[J].Genome Res,2009,19(1):92-105.DOI: 10.1101/gr.082701.108.
    [23] MengZ,ZhouD,GaoY,et al.miRNA delivery for skin wound healing[J].Adv Drug Deliv Rev,2018,129:308-318.DOI: 10.1016/j.addr.2017.12.011.
    [24] MulhollandEJ,DunneN,McCarthyHO.MicroRNA as therapeutic targets for chronic wound healing[J].Mol Ther Nucleic Acids,2017,8:46-55.DOI: 10.1016/j.omtn.2017.06.003.
    [25] FahsF, BiX, YuFS, et al. New insights into microRNAs in skin wound healing[J]. IUBMB Life, 2015,67(12):889-896. DOI: 10.1002/iub.1449.
    [26] LiD,LiXI,WangA,et al.MicroRNA-31 promotes skin wound healing by enhancing keratinocyte proliferation and migration[J].J Invest Dermatol,2015,135(6):1676-1685.DOI: 10.1038/jid.2015.48.
    [27] DeppeJ,SteinritzD,SantovitoD,et al.Upregulation of miR-203 and miR-210 affect growth and differentiation of keratinocytes after exposure to sulfur mustard in normoxia and hypoxia[J].Toxicol Lett,2016,244:81-87.DOI: 10.1016/j.toxlet.2015.09.012.
  • 1  原代人羊膜上皮细胞(hAEC)培养第2、4、7天形态观察 倒置荧光显微镜×100。1A.培养第2天,hAEC贴壁生长,形态、大小均一;1B、1C.分别为培养第4、7天,hAEC增殖活跃,细胞密度增加,呈典型的鹅卵石样单层排列

    2  人羊膜上皮细胞外泌体(hAEC-Exo)与HaCaT共培养3 h,hAEC-Exo被HaCaT内吞入细胞质,并聚集于细胞核周围 PKH26-4',6-二脒基-2-苯基吲哚×200

    注:红色指示外泌体,蓝色指示细胞核

    3  2组HaCaT划痕后各时间点划痕面积 倒置荧光显微镜×100。3A、3B、3C、3D.分别为PBS组划痕后0(即刻)、24、48、72 h的划痕面积;3E、3F、3G、3H.分别为hAEC-Exo组划痕后0、24、48、72 h的划痕面积,图3F、3G、3H划痕面积分别明显小于图3B、3C、3D

    注:PBS为磷酸盐缓冲液,hAEC-Exo为人羊膜上皮细胞外泌体

    4  Transwell实验观察2组HaCaT培养48 h穿膜迁移情况 苏木精×50。4A、4B.分别为PBS组和hAEC-Exo组,图4B穿膜细胞数明显多于图4A

    注:蓝色指示穿膜细胞;PBS为磷酸盐缓冲液,hAEC-Exo为人羊膜上皮细胞外泌体

    5  蛋白质印迹法检测2组HaCaT培养24 h PI3K-Akt-mTOR通路相关蛋白的表达水平

    注:PI3K为磷脂酰肌醇3-激酶,mTOR为哺乳动物雷帕霉素靶蛋白,p-mTOR为磷酸化mTOR,Akt为蛋白激酶B,p-Akt为磷酸化Akt,GAPDH为3-磷酸甘油醛脱氢酶;1、2分别为磷酸盐缓冲液组和人羊膜上皮细胞外泌体组

    6  蛋白质印迹法检测3组HaCaT培养24 h PI3K-Akt-mTOR通路相关蛋白的表达量

    注:PI3K为磷脂酰肌醇3-激酶,mTOR为哺乳动物雷帕霉素靶蛋白,p-mTOR为磷酸化mTOR,Akt为蛋白激酶B,p-Akt为磷酸化Akt,GAPDH为3-磷酸甘油醛脱氢酶;1、2、3分别为二甲基亚砜(DMSO)+磷酸盐缓冲液组,DMSO+人羊膜上皮细胞外泌体(hAEC-Exo)组,LY294002+hAEC-Exo组

    7  3组HaCaT划痕后各时间点划痕面积。7A、7B、7C、7D.分别为DMSO+PBS组划痕后0(即刻)、24、48、72 h的划痕面积;7E、7F、7G、7H.分别为DMSO+hAEC-Exo组划痕后0、24、48、72 h的划痕面积,图7F、7G、7H划痕面积明显小于图7B、7C、7D;7I、7J、7K、7L.分别为LY294002+hAEC-Exo组划痕后0、24、48、72 h的划痕面积,图7J、7K、7L划痕面积明显大于图7F、7G、7H

    注:DMSO为二甲基亚砜,PBS为磷酸盐缓冲液,hAEC-Exo为人羊膜上皮细胞外泌体

    8  Transwell实验观察3组HaCaT培养48 h穿膜迁移情况 苏木精×50。8A、8B、8C.分别为DMSO+PBS组、DMSO+hAEC-Exo组和LY294002+hAEC-Exo组,图8B穿膜迁移细胞数明显多于图8A、8C

    注:图中蓝色指示穿膜细胞;DMSO为二甲基亚砜, PBS为磷酸盐缓冲液,hAEC-Exo为人羊膜上皮细胞外泌体

    表 1  2组HaCaT培养各时间点增殖活力比较(x¯±s

    组别样本数12 h24 h36 h48 h60 h
    PBS组30.273±0.0250.386±0.0280.494±0.0300.789±0.0600.943±0.040
    hAEC-Exo组30.404±0.0300.770±0.0410.923±0.0261.161±0.0421.471±0.038
    t3.69110.86112.12110.53114.931
    P<0.01<0.01<0.01<0.01<0.01
    注:PBS为磷酸盐缓冲液,hAEC-Exo为人羊膜上皮细胞外泌体;处理因素主效应,F=783.2,P<0.01;时间因素主效应,F=494.7,P<0.01;两者交互作用,F=27.0,P<0.01
    下载: 导出CSV

    表2  2组HaCaT划痕后各时间点划痕愈合率比较

    表2.   (%,x¯±s)

    组别样本数24 h48 h72 h
    PBS组322.6±2.442.8±4.074.5±4.5
    hAEC-Exo组334.7±4.966.1±4.894.4±4.1
    t3.3426.4275.485
    P<0.05<0.01<0.01
    注:PBS为磷酸盐缓冲液,hAEC-Exo为人羊膜上皮细胞外泌体;处理因素主效应,F=692.7,P<0.01;时间因素主效应,F=25.4,P<0.01;两者交互作用,F=14.4,P<0.01
    下载: 导出CSV

    表3  2组HaCaT培养24 h PI3K-Akt-mTOR通路相关蛋白的表达量比较(x¯±s

    组别样本数mTORp-mTORAktp-Akt
    PBS组30.517±0.0450.267±0.0660.823±0.0680.333±0.050
    hAEC-Exo组30.537±0.0490.437±0.0460.787±0.0250.610±0.029
    t0.4044.2400.7405.586
    P>0.05<0.01>0.05<0.01
    注:PBS为磷酸盐缓冲液,hAEC-Exo为人羊膜上皮细胞外泌体;PI3K为磷脂酰肌醇3-激酶,Akt为蛋白激酶B,p-Akt为磷酸化Akt,mTOR为哺乳动物雷帕霉素靶蛋白,p-mTOR为磷酸化mTOR
    下载: 导出CSV

    表4  3组HaCaT中培养24 h PI3K-Akt-mTOR通路相关蛋白的表达量比较(x¯±s

    组别样本数mTORp-mTORAktp-Akt
    DMSO+PBS组30.716±0.0170.395±0.0380.859±0.0330.228±0.028
    DMSO+hAEC-Exo组30.716±0.0260.600±0.0540.847±0.0290.505±0.034
    LY294002+hAEC-Exo组30.699±0.0270.433±0.0290.865±0.0390.374±0.033
    F0.413.80.138.3
    P>0.05<0.01>0.05<0.01
    t10.0246.1550.3538.338
    P1>0.05<0.01>0.05<0.01
    t20.5015.0300.5173.960
    P2>0.05<0.01>0.05<0.01
    注:DMSO为二甲基亚砜,PBS为磷酸盐缓冲液,hAEC-Exo为人羊膜上皮细胞外泌体,PI3K为磷脂酰肌醇3-激酶,Akt为蛋白激酶B,p-Akt为磷酸化Akt,mTOR为哺乳动物雷帕霉素靶蛋白,p-mTOR为磷酸化mTOR;t1值、P1值,t2值、P2值分别DMSO+hAEC-Exo组与DMSO+PBS组、LY294002+hAEC-Exo组比较所得
    下载: 导出CSV

    表5  3组HaCaT培养各时间点增殖活力比较(x¯±s

    组别样本数12 h24 h36 h48 h60 h
    DMSO+PBS组30.46±0.040.69±0.070.98±0.081.16±0.081.26±0.11
    DMSO+hAEC-Exo组30.78±0.051.23±0.071.60±0.091.86±0.092.03±0.08
    LY294002+hAEC-Exo组30.59±0.030.96±0.091.20±0.081.39±0.081.55±0.10
    t14.3767.3988.4889.76610.730
    P1<0.01<0.01<0.01<0.01<0.01
    t22.6913.6395.4476.6056.693
    P2>0.05<0.05<0.01<0.01<0.01
    注:DMSO为二甲基亚砜,PBS为磷酸盐缓冲液,hAEC-Exo为人羊膜上皮细胞外泌体;处理因素主效应,F=141.3,P<0.01;时间因素主效应,F=279.1,P<0.01;两者交互作用,F=8.2,P<0.01;t1值、P1值,t2值、P2值分别DMSO+hAEC-Exo组与DMSO+PBS组、LY294002+hAEC-Exo组比较所得
    下载: 导出CSV

    表6  3组HaCaT培养各时间点划痕愈合率比较(%,x¯±s

    组别样本数24 h48 h72 h
    DMSO+PBS组311.2±1.535.2±4.471.2±3.4
    DMSO+hAEC-Exo组323.0±2.054.0±3.994.0±2.9
    LY294002+hAEC-Exo组311.8±1.840.1±2.582.0±2.9
    t14.0036.3497.714
    P1<0.01<0.01<0.01
    t23.8054.6764.067
    P2<0.05<0.01<0.01
    注:DMSO为二甲基亚砜,PBS为磷酸盐缓冲液,hAEC-Exo为人羊膜上皮细胞外泌体;处理因素主效应,F=779.4,P<0.01;时间因素主效应,F=57.1,P<0.01;两者交互作用,F=2.2,P=0.11;t1值、P1值,t2值、P2值分别DMSO+hAEC-Exo组与DMSO+PBS组、LY294002+hAEC-Exo组比较所得
    下载: 导出CSV
  • 加载中
图(8) / 表(6)
计量
  • 文章访问数:  421
  • HTML全文浏览量:  87
  • PDF下载量:  46
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-04-24

目录

    /

    返回文章
    返回